Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis
Affiliation
Department of Obstetrics and Gynecology, Qilu Hospital, Shandong University, 107 W. Wenhua Road, Jinan, Shandong, China 250012Department of Pathology, University of Arizona College of Medicine, Tucson, AZ, USA
Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN, USA
Department of Obstetrics and Gynecology, University of Arizona, Tucson, AZ, USA
Arizona Cancer Center, University of Arizona, Tucson, AZ, USA
Department of Pathology, University of Arizona, 1501 N. Campbell Avenue, #5224A, Tucson, AZ 85724, USA
Issue Date
2012
Metadata
Show full item recordPublisher
BioMed CentralCitation
Li et al. Journal of Hematology & Oncology 2012, 5:8 http://www.jhoonline.org/content/5/1/8Journal
Journal of Hematology & OncologyRights
© 2012 Li et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0).Collection Information
This item is part of the UA Faculty Publications collection. For more information this item or other items in the UA Campus Repository, contact the University of Arizona Libraries at repository@u.library.arizona.edu.Abstract
Recent morphologic and molecular genetic studies have led to a paradigm shift in our conceptualization of the carcinogenesis and histogenesis of pelvic (non-uterine) serous carcinomas. It appears that both low-grade and high-grade pelvic serous carcinomas that have traditionally been classified as ovarian in origin, actually originate, at least in a significant subset, from the distal fallopian tube. Clonal expansions of the tubal secretory cell probably give rise to serous carcinomas, and the degree of ciliated conversion is a function of the degree to which the genetic hits deregulate normal differentiation. In this article, the authors review the evidentiary basis for aforementioned paradigm shift, as well as its potential clinical implications.EISSN
1756-8722Version
Final published versionAdditional Links
http://www.jhoonline.org/content/5/1/8ae974a485f413a2113503eed53cd6c53
10.1186/1756-8722-5-8
Scopus Count
Collections
Except where otherwise noted, this item's license is described as © 2012 Li et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0).

